MRK vs RMD
By Alex · Tickerpine
Merck & Co., Inc. vs ResMed Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | MRK | RMD |
|---|---|---|
| Price | $156.45 | $236.59 |
| Market cap | $385.99B | $34.13B |
| P/E ratio | 120.3 | 22.3 |
| ROE | 6.96% | 24.27% |
| Profit margin | 4.77% | 26.95% |
| Revenue growth | 5.10% | 8.60% |
| Dividend yield | 2.26% | 1.14% |
| Beta | 0.21 | 0.75 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
MRK vs RMD in plain English
- MRK is the bigger company — about 11.3× the market cap of RMD.
- RMD is cheaper on earnings (P/E 22.3 vs 120.3).
- RMD earns a higher return on equity (24% vs 7%).
- RMD is growing revenue faster (9% vs 5%).
- MRK has the higher dividend yield (2.26% vs 1.14%).
How would $1,000 have done in each?
MRK return calculator
See what $1,000 in Merck & Co., Inc. would be worth today.
RMD return calculator
See what $1,000 in ResMed Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.